ASCO has published a guideline on preventing and monitoring cardiac dysfunction in survivors of adult cancers, stressing that health care providers need to initiate the discussion about potential cardiac-related toxicities before cancer treatment begins.
Authors discuss the state of international quality standards for cancer care—particularly in Spain—and how the ECO Foundation and ASCO’s Quality Oncology Practice Initiative are working to continue improving them.
ASCO is keenly aware of the need for easily accessible, physician-approved resources to help oncology care teams and their patients make informed decisions about weight management after a cancer diagnosis.
During “Constructing a Care Team for Under-Resourced Populations: Reaching the Hard-to-Reach with a Multidisciplinary Approach,” speakers will discuss how to leverage resources and provide high-quality care against a backdrop of limited time, funds, and personnel.
Susan G. Braun, MA, FASCO, is receiving the 2016 Partners in Progress Award for her work in advancing cancer care as the leader of several high-profile cancer organizations, including The Conquer Cancer Foundation® of ASCO, the Susan G. Komen® foundation, and The V Foundation for Cancer Research.
Experts discuss the disparities among cancer survivors returning to work, the barriers they must overcome, and the accommodations and steps that clinicians and ASCO members must take to help them succeed.
Palliative radiotherapy effectively eases cancer-related symptoms, but how palliative radiation therapy should be delivered—including treatment intensity and degree of technological sophistication in dose delivery—is often debated.
Dr. Stephen T. Sonis discusses advances in the science, epidemiology, and pharmacokinetics of regimen-related toxicities as well as the obstacles that remain in predicting risk for treatment-related toxicity.
Patients are occasionally unaware of their true cancer care prognosis and misinterpret the value of interventions, assigning higher value to treatments than is accurate, sometimes especially for treatments that cost more.